Trial Site Detail

 

Drug:
NB003
Trial:
A Study of NB003 in Patients With Advanced Malignancies
Conditions: Solid Tumors
Trial Status:
Recruiting

 

Tianjin Medical University Cancer Institute & Hospital

     
Tianjin , Tianjin 453000
China

 

Principal Investigator:
Han Liang
Contact:
Activation Status of this Site:
Active
Notes about this Site:
Tianjin Medical University Cancer Institute & Hospital Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.